Skip to main content
OpenTrials

Clinical trial condition

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

294 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations
  • Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
  • AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
View Trial Details
Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

NCT00499811

Conditions
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • National Institutes of Health Bethesda, Maryland, United States
View Trial Details
Completed

Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma

NCT00006383

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
View Trial Details

Related conditions